Stocks
Recro Pharma, Inc.REPH
NASDAQHealthcareBiotechnology$2.09-0.48%
Specializing in contract development and manufacturing for pharmaceutical products, this company provides services for both clinical and commercial-stage drug delivery. Investors monitor its performance due to its role in supporting drug commercialization for biotech and pharma clients. Its revenue streams are tied to outsourcing trends in the pharmaceutical industry.
Market Cap: $177.4M52W Range: $1.38 – $3.29
Congressional Interest in Recro Pharma, Inc. (REPH)
No congressional trades have been disclosed for Recro Pharma, Inc. (REPH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading REPH?
No congressional trades found for this stock.